Active Ingredient History
Raltitrexed is an antimetabolite drug used in cancer chemotherapy. It is an inhibitor of thymidylate synthase, and is manufactured by AstraZeneca. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 2)
Adenoma (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Chemoembolization, Therapeutic (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 4)
Drugs, Investigational (Phase 1/Phase 2)
Esophageal Neoplasms (Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Liver Neoplasms (Phase 4)
Mesothelioma, Malignant (Phase 3)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms ()
Pancreatic Neoplasms (Phase 2)
Rectal Neoplasms (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 4)
Stomach Neoplasms (Phase 2)
Thrombocytopenia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue